This article has been updated with comments from PQDNA CEO Andre Gous.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has notified three more companies marketing genetic tests directly to consumers that their tests make medical claims, appear to qualify as medical devices, and should be regulated.

The firms that received letters include Lumigenix, American International Biotechnology Services (AIBiotech), and Precision Quality DNA (PQDNA).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.